Predominance of multidrug-resistant bacteria causing urinary tract infections among symptomatic patients in East Africa: a call for action.

IF 3.7 Q2 INFECTIOUS DISEASES
JAC-Antimicrobial Resistance Pub Date : 2024-02-14 eCollection Date: 2024-02-01 DOI:10.1093/jacamr/dlae019
Antonio Maldonado-Barragán, Stephen E Mshana, Katherine Keenan, Xuejia Ke, Stephen H Gillespie, John Stelling, John Maina, Joel Bazira, Ivan Muhwezi, Martha F Mushi, Dominique L Green, Mike Kesby, Andy G Lynch, Wilber Sabiiti, Derek J Sloan, Alison Sandeman, John Kiiru, Benon Asiimwe, Matthew T G Holden
{"title":"Predominance of multidrug-resistant bacteria causing urinary tract infections among symptomatic patients in East Africa: a call for action.","authors":"Antonio Maldonado-Barragán, Stephen E Mshana, Katherine Keenan, Xuejia Ke, Stephen H Gillespie, John Stelling, John Maina, Joel Bazira, Ivan Muhwezi, Martha F Mushi, Dominique L Green, Mike Kesby, Andy G Lynch, Wilber Sabiiti, Derek J Sloan, Alison Sandeman, John Kiiru, Benon Asiimwe, Matthew T G Holden","doi":"10.1093/jacamr/dlae019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In low- and middle-income countries, antibiotics are often prescribed for patients with symptoms of urinary tract infections (UTIs) without microbiological confirmation. Inappropriate antibiotic use can contribute to antimicrobial resistance (AMR) and the selection of MDR bacteria. Data on antibiotic susceptibility of cultured bacteria are important in drafting empirical treatment guidelines and monitoring resistance trends, which can prevent the spread of AMR. In East Africa, antibiotic susceptibility data are sparse. To fill the gap, this study reports common microorganisms and their susceptibility patterns isolated from patients with UTI-like symptoms in Kenya, Tanzania and Uganda. Within each country, patients were recruited from three sites that were sociodemographically distinct and representative of different populations.</p><p><strong>Methods: </strong>UTI was defined by the presence of >10<sup>4</sup> cfu/mL of one or two uropathogens in mid-stream urine samples. Identification of microorganisms was done using biochemical methods. Antimicrobial susceptibility testing was performed by the Kirby-Bauer disc diffusion assay. MDR bacteria were defined as isolates resistant to at least one agent in three or more classes of antimicrobial agents.</p><p><strong>Results: </strong>Microbiologically confirmed UTI was observed in 2653 (35.0%) of the 7583 patients studied. The predominant bacteria were <i>Escherichia coli</i> (37.0%), <i>Staphylococcus</i> spp. (26.3%), <i>Klebsiella</i> spp. (5.8%) and <i>Enterococcus</i> spp. (5.5%). <i>E. coli</i> contributed 982 of the isolates, with an MDR proportion of 52.2%. <i>Staphylococcus</i> spp. contributed 697 of the isolates, with an MDR rate of 60.3%. The overall proportion of MDR bacteria (<i>n</i> = 1153) was 50.9%.</p><p><strong>Conclusions: </strong>MDR bacteria are common causes of UTI in patients attending healthcare centres in East African countries, which emphasizes the need for investment in laboratory culture capacity and diagnostic algorithms to improve accuracy of diagnosis that will lead to appropriate antibiotic use to prevent and control AMR.</p>","PeriodicalId":14594,"journal":{"name":"JAC-Antimicrobial Resistance","volume":"6 1","pages":"dlae019"},"PeriodicalIF":3.7000,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10873138/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAC-Antimicrobial Resistance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jacamr/dlae019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In low- and middle-income countries, antibiotics are often prescribed for patients with symptoms of urinary tract infections (UTIs) without microbiological confirmation. Inappropriate antibiotic use can contribute to antimicrobial resistance (AMR) and the selection of MDR bacteria. Data on antibiotic susceptibility of cultured bacteria are important in drafting empirical treatment guidelines and monitoring resistance trends, which can prevent the spread of AMR. In East Africa, antibiotic susceptibility data are sparse. To fill the gap, this study reports common microorganisms and their susceptibility patterns isolated from patients with UTI-like symptoms in Kenya, Tanzania and Uganda. Within each country, patients were recruited from three sites that were sociodemographically distinct and representative of different populations.

Methods: UTI was defined by the presence of >104 cfu/mL of one or two uropathogens in mid-stream urine samples. Identification of microorganisms was done using biochemical methods. Antimicrobial susceptibility testing was performed by the Kirby-Bauer disc diffusion assay. MDR bacteria were defined as isolates resistant to at least one agent in three or more classes of antimicrobial agents.

Results: Microbiologically confirmed UTI was observed in 2653 (35.0%) of the 7583 patients studied. The predominant bacteria were Escherichia coli (37.0%), Staphylococcus spp. (26.3%), Klebsiella spp. (5.8%) and Enterococcus spp. (5.5%). E. coli contributed 982 of the isolates, with an MDR proportion of 52.2%. Staphylococcus spp. contributed 697 of the isolates, with an MDR rate of 60.3%. The overall proportion of MDR bacteria (n = 1153) was 50.9%.

Conclusions: MDR bacteria are common causes of UTI in patients attending healthcare centres in East African countries, which emphasizes the need for investment in laboratory culture capacity and diagnostic algorithms to improve accuracy of diagnosis that will lead to appropriate antibiotic use to prevent and control AMR.

在东非有症状的患者中,引起尿路感染的耐多药细菌占主导地位:呼吁采取行动。
背景:在低收入和中等收入国家,有尿路感染(UTI)症状的患者通常会在未经微生物学确认的情况下被处方抗生素。抗生素使用不当会导致抗菌药耐药性(AMR)和耐药菌的产生。培养细菌的抗生素敏感性数据对于起草经验性治疗指南和监测耐药性趋势非常重要,可防止 AMR 的扩散。在东非,抗生素敏感性数据很少。为填补这一空白,本研究报告了从肯尼亚、坦桑尼亚和乌干达出现类似UTI症状的患者中分离出的常见微生物及其药敏模式。每个国家都从社会人口统计学上不同且代表不同人群的三个地点招募患者:UTI的定义是中段尿液样本中出现>104 cfu/mL的一种或两种尿路病原体。微生物的鉴定采用生化方法。抗菌药敏感性测试采用柯比鲍尔盘扩散法进行。MDR 细菌的定义是对三种或三种以上抗菌剂中至少一种抗菌剂具有耐药性的分离菌:在研究的 7583 例患者中,有 2653 例(35.0%)经微生物确诊为尿毒症。主要细菌为大肠埃希菌(37.0%)、葡萄球菌属(26.3%)、克雷伯氏菌属(5.8%)和肠球菌属(5.5%)。大肠杆菌占分离菌株总数的 982%,其中耐药菌比例为 52.2%。分离到的葡萄球菌有 697 株,耐药率为 60.3%。MDR 细菌的总体比例(n = 1153)为 50.9%:东非国家医疗中心的尿毒症患者中,MDR 细菌是常见的致病原因,因此需要对实验室培养能力和诊断算法进行投资,以提高诊断的准确性,从而合理使用抗生素,预防和控制 AMR。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信